Abatacept for lupus nephritis: Alternative definitions of complete response support conflicting conclusions-Reference-Cited by-同舟云学术

Abatacept for lupus nephritis: Alternative definitions of complete response support conflicting conclusions

Published:2012-10-27 Issue:11 Volume:64 Page:3660-3665
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Wofsy David,Hillson Jan L.,Diamond Betty

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.34624/fullpdf

Reference15 articles.

1. Efficacy and safety of abatacept over 12 months in patients with lupus nephritis: results from a multicenter, randomized, double-blind, placebo-controlled phase II/III study;Furie;Arthritis Rheum,2011

2. Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs;Austin;N Engl J Med,1986

3. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide;Houssiau;Arthritis Rheum,2002

4. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide;Houssiau;Ann Rheum Dis,2010

5. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis;Appel;J Am Soc Nephrol,2009

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS;Kidney International;2024-01

2. Targeted therapies for lupus nephritis: Current perspectives and future directions;Chinese Medical Journal;2023-12-07

3. Experience with abatacept in refractory lupus nephritis;Rheumatology International;2023-08-31

4. Urine biomarker score captures response to induction therapy with lupus nephritis;Pediatric Nephrology;2023-01-30

5. The star target in SLE: IL-17;Inflammation Research;2022-12-20